Patient was found to have UTI at chronic care facility and wsa given levaquin x 5 days then macrobid after, but continued to spike 101.
In [**Name (NI) **] pt was given solumedrol and neb en route for COPD exacerbation and went to 97% on 4L.
Patient was then placed on BIPAP and transferred to [**Hospital Unit Name 153**].
Pertinent Results: [**2140-7-20**] 03:30PM BLOOD WBC-9.3 RBC-3.89* Hgb-11.8* Hct-37.2 MCV-96 MCH-30.3 MCHC-31.6 RDW-13.9 Plt Ct-199 [**2140-7-20**] 03:30PM BLOOD Neuts-46.8* Lymphs-45.0* Monos-4.2 Eos-3.8 Baso-0.3 [**2140-7-21**] 01:00AM BLOOD Glucose-159* UreaN-28* Creat-0.6 Na-147* K-4.9 Cl-105 HCO3-38* AnGap-9 [**2140-7-23**] 07:23AM BLOOD Type-ART Temp-36.4 Rates-/35 O2 Flow-36 pO2-141* pCO2-59* pH-7.39 calHCO3-37* Base XS-8 [**2140-7-22**] 02:54AM BLOOD Type-ART PEEP-10 O2-35 pO2-85 pCO2-71* pH-7.33* calHCO3-39* Base XS-7 Intubat-NOT INTUBA [**2140-7-20**] 09:47PM BLOOD Type-ART pO2-65* pCO2-100* pH-7.24* calHCO3-45* Base XS-10 [**2140-7-23**] 07:23AM BLOOD Glucose-113* Lactate-1.4 Na-144 K-5.0 Cl-108 [**2140-7-20**] 10:15PM URINE  HOURS-RANDOM SODIUM-17 CALCIUM-11.4 [**2140-7-20**] 10:15PM URINE  OSMOLAL-590 [**2140-7-20**] 06:00PM URINE  BLOOD-TR NITRITE-NEG PROTEIN-NEG GLUCOSE-NEG KETONE-TR BILIRUBIN-NEG UROBILNGN-NEG PH-5.0 LEUK-NEG [**2140-7-20**] 06:00PM URINE  RBC-0 WBC-<1 BACTERIA-NONE YEAST-NONE EPI-<1  CXR ([**2140-7-20**]) FINDINGS: The heart is top normal in size and the mediastinal contours are unremarkable.
Brief Hospital Course: 1) Respiratory failure: Patient was transferred to ICU for NIMV for hypoxia and hypercapnea for presumable COPD exacerbation.
Patient was given Solu-medrol and nebulizer which showed improvement.
BIPAP was weaned off, however, patient became intermittently somnolent on nasal cannula and had to be put back on BIPAP.
Patient continued to have day time somnolence with desaturations on nasal canula requiring BIPAP.
Solu-medrol was taper to prednisone po and patient will be discharged with prednisone taper.
Doxycycline was initially started for possible infectious cause as a trigger.
Since CXR was unlikely for pneumonia, doxycycline was discontinued in 2 days.
Patient did well with nasal canula the last 36 hrs but there is a possibility that patient may become somnolent and hypoxic again.
Patient remained on Zyprexa, Ativan, Depakote throughout admission.
Medications on Admission: Synthroid Depakote Zyprexa ASA Vitamin C Ativan Ranitidine Macrobid  Discharge Medications: 1.
Multivitamin     Capsule Sig: One (1) Cap PO QD (once a day).
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Levothyroxine Sodium 112 mcg Tablet Sig: One (1) Tablet PO QD (once a day).
Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO QD (once a day).
Ascorbic Acid 500 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed.
Pantoprazole Sodium 40 mg Tablet, Delayed Release (E.C.)
Divalproex Sodium 125 mg Capsule, Sprinkle Sig: Two (2) Capsule, Sprinkle PO QAM (once a day (in the morning)).
Divalproex Sodium 125 mg Capsule, Sprinkle Sig: One (1) Capsule, Sprinkle PO QHS (once a day (at bedtime)).
Heparin Sodium (Porcine) 5,000 unit/mL Solution Sig: 5000 (5000) units Injection Q12H (every 12 hours).
Albuterol-Ipratropium 103-18 mcg/Actuation Aerosol Sig: [**1-15**] Puffs Inhalation Q6H (every 6 hours).
Zyprexa 5 mg Tablet Sig: One (1) Tablet PO qAM.
Zyprexa 2.5 mg Tablet Sig: One (1) Tablet PO qPM.
Calcium Carbonate 500 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO TID W/MEALS (3 TIMES A DAY WITH MEALS).
Prednisone 10 mg Tablet Sig: Five (5) Tablet PO qd () for 2 doses.
Prednisone 20 mg Tablet Sig: Two (2) Tablet PO qd () for 2 doses.
Prednisone 10 mg Tablet Sig: Three (3) Tablet PO qd () for 2 doses.
Prednisone 20 mg Tablet Sig: One (1) Tablet PO qd () for 2 doses.
Prednisone 10 mg Tablet Sig: One (1) Tablet PO qd () for 2 doses.
Prednisone 5 mg Tablet Sig: One (1) Tablet PO qd () for 2 doses.
Nystatin 100,000 unit/mL Suspension Sig: Five (5) ML PO QID (4 times a day) as needed.
Albuterol Sulfate 0.083 % Solution Sig: [**1-15**]  Inhalation Q6H (every 6 hours).
Ipratropium Bromide 0.02 % Solution Sig: [**1-15**]  Inhalation Q6H (every 6 hours).
Kyphosis 6.
Patient was breathing comfortably without mask ventilation at the time of discharge.
Discharge Instructions: Patient may need to have oxygen via nasal canula if she becomes hypoxic but no further intervention (BIPAP) is needed.
